Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for preventing and treating atherosclerotic plaque and preparation method thereof

A technology for atherosclerosis and drugs, applied in the direction of drug combinations, pharmaceutical formulas, medical preparations containing active ingredients, etc., can solve the problems of low curative effect, long course of treatment, toxic and side effects, etc., and achieve simple preparation process and easy-to-obtain materials , moderately priced effect

Active Publication Date: 2016-08-03
SOUTHERN MEDICAL UNIVERSITY
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented inventor describes an effective way to treat diseases caused by excessive body temperature or lack therapy. It uses certain plants like Gardenia and Coptis that help reduce sweatiness during exercise. These plant extractives can be added separately but they work together synergistically when mixed properly. They also have anti-inflammatory properties which make them useful against inflammations such as arthritis. Overall these ingredients improve their ability to remove unwanted substances from our bodies effectively while reducing pain associated therewith.

Problems solved by technology

This patented technical solution involves developing new herbal or plant extractives from plants called tianspora sinensis which could help stop platelet aggregates and block excess fluid buildup caused by hyperchlorophyll bacteremia. These ingredients may even enhance healing responses during reperfused microcirculatory conditions like sepsis due to their ability to promote vasogenesis without causing harmful complications associated with conventional remedy options used alone.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for preventing and treating atherosclerotic plaque and preparation method thereof
  • Medicine for preventing and treating atherosclerotic plaque and preparation method thereof
  • Medicine for preventing and treating atherosclerotic plaque and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Embodiment 1 (granule)

[0086] 1. Prescription

[0087] Gardenia 615, Coptidis 615, Polygonum cuspidatum 922.5, Cassia 922.5, Salvia miltiorrhiza 1230, Panax notoginseng 615, Quanguanlou 615, Chishao 615.

[0088] 2. Preparation method

[0089] (1) Take the raw material medicine, add water and decoct 3 times, decoct with high heat for 30 minutes after the first boiling, 1 hour for 1 hour after the second boiling, and 1.5 hours for 1.5 hours after the third boiling;

[0090] (2) Then combine the decoctions, filter and concentrate the filtrate at 80°C to a clear paste with a relative density of 1.25, put it in an oven at 75°C to dry into a dry paste, and grind it into fine powder;

[0091] (3) Add appropriate amount of dextrin and starch to the obtained dry cream powder to 1000g, add water to make granules, then dry, granulate, and pack into 9g / package (each contains about 5.4g of drug dry powder).

Embodiment 2

[0092] Embodiment 2 (granule)

[0093] 1. Prescription

[0094] Gardenia 431g, Coptidis 507g, Polygonum cuspidatum 849g, Cassia 1042g, Salvia miltiorrhiza 1488g, Panax notoginseng 685g, Trichosanthes 596g, Chishao 507g.

[0095] 2. Preparation method

[0096] (1) Take the raw material medicine, add water and decoct 3 times, decoct with high heat for 30 minutes after the first boiling, 1 hour for 1 hour after the second boiling, and 1.5 hours for 1.5 hours after the third boiling;

[0097] (2) Then combine the decoctions, filter and concentrate the filtrate at 80°C to a clear paste with a relative density of 1.25, put it in an oven at 75°C to dry into a dry paste, and grind it into fine powder;

[0098] (3) Add appropriate amount of dextrin and starch to the obtained dry cream powder to 1000g, add water to make granules, then dry, granulate, and pack into 15g / package (each contains about 5.4g of drug dry powder).

Embodiment 3

[0099] Embodiment 3 (granule)

[0100] 1. Prescription

[0101] Gardenia 800g, Coptidis 700g, Polygonum cuspidatum 923g, Cassia 769g, Salvia miltiorrhiza 1382g, Panax notoginseng 431g, Trichopina 523g, Chishao 622g.

[0102] 2. Preparation method

[0103] (1) Take the raw material medicine, add water and decoct 3 times, decoct with high heat for 30 minutes after the first boiling, 1 hour for 1 hour after the second boiling, and 1.5 hours for 1.5 hours after the third boiling;

[0104] (2) Then combine the decoctions, filter and concentrate the filtrate at 80°C to a clear paste with a relative density of 1.25, put it in an oven at 75°C to dry into a dry paste, and grind it into fine powder;

[0105] (3) Add appropriate amount of dextrin and starch to the obtained dry cream powder to 1000g, add water to make granules, then dry, granulate, and pack into 13.8g / package (each contains about 5.4g of drug dry powder).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating atherosclerotic plaque. The medicine comprises effective ingredients and pharmaceutically acceptable excipient, wherein the effective ingredients are prepared from the following medicinal raw materials in percentage by weight: 7-13 percent of cape jasmine, 7-13 percent of coptis chinensis, 10-20 percent of polygonum cuspidatum, 10-20 percent of semen cassiae, 15-25 percent of salvia miltiorrhiza, 7-13 percent of pseudo-ginseng, 7-13 percent of trichosanthes ovigera and 7-13 percent of radix paeoniae rubra. The medicine can be granules, capsule or tablets and other oral preparations for treating atherosclerotic plaque. Clinical application verifies that the medicine has the advantages of quick symptoms improvement and short course of treatment.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Owner SOUTHERN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products